Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: A population-based study in Shanghai, China

British Journal of Cancer

Volumn 105, Issue 9, 2011, Pages 1424-1429

  Shebl, F M ^a   Andreotti, G ^a   Meyer, T E ^a   Gao, Y T ^b   Rashid, A ^c   Yu, K ^a   Shen, M C ^d   Wang, B S ^d   Han, T Q ^e   Zhang, B H ^f   Stanczyk, F Z ^g   Hsing, A W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d FUDAN UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

biliary stones; biliary tract cancers; insulin resistance; metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BILE DUCT STONE; BILIARY TRACT CANCER; CANCER RISK; CELL FUNCTION; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PANCREAS ISLET BETA CELL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BILIARY TRACT NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GALLSTONES; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X;

EID: 80054971046     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.363     Document Type: Article

References (30)

1. Abe R, Yamagishi S (2008) AGE-RAGE system and carcinogenesis. Curr Pharm Des 14: 940-945 (Pubitemid 351753280)
2. Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, Wang BS, Han TQ, Zhang BH, Danforth KN, Althuis MD, Hsing AW (2008) Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer 122: 2322-2329 (Pubitemid 351542338)
3. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17: 4-12
4. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169: 1505-1522 (Pubitemid 351181984)
5. de Luca C, Olefsky JM (2008) Inflammation and insulin resistance. FEBS Lett 582: 97-105 (Pubitemid 50010731)
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752 (Pubitemid 41532612)
7. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, Fraumeni Jr JF (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97: 1577-1582 (Pubitemid 350175843)
8. Hsing AW, Rashid A, Devesa SS, Fraumeni Jr JF (2006) Biliary tract cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer Epidemiology and Prevention, 3rd edn. Oxford University Press, Inc.: New York, pp 787-800
9. Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, Han TQ, Wang BS, Gao YT (2008) Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99: 811-815
10. Ishiguro S, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S (2008) Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control 19: 33-41
11. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ (2001) Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 120: 190-199 (Pubitemid 32061883)
12. Janowitz P, Wechsler JG, Kuhn K, Kratzer W, Tudyka J, Swobodnik W, Ditschuneit H (1992) The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones. Clin Investig 70: 430-436
13. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (2007) Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 35: 390-419
14. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders AE, Lamers CH, Masclee AA (2003) Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut 52: 109-115 (Pubitemid 36020775)
15. Kodama H, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S, Nakagawa K (1999) Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men. Int J Obes Relat Metab Disord 23: 211-216 (Pubitemid 29057518)
16. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192 (Pubitemid 28549174)
17. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L, Tuomi T (2005) Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54: 166-174 (Pubitemid 40105109)
18. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC (1989) Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 321: 563-569 (Pubitemid 19212867)
19. Maurer KJ, Carey MC, Fox JG (2009) Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 136: 425-440
20. National Institutes of Health, National Heart, Lung, and Blood Institute (1995) National Cholesterol Education Program, Recommendations on Lipoprotein Measurement from the Working Group on Lipoprotein Measurement. NIH Publication No. 95-3044: Bethesda, MD
21. Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246
22. Rifai N, Warnick GR, McNamara JR, Belcher JD, Grinstead GF, Frantz Jr ID (1992) Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem 38: 150-160
23. Seidell JC (2010) Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clin Nutr 64: 35-41
24. Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, Shen MC, Wang BS, Li Q, Han TQ, Zhang BH, Fraumeni Jr JF, Hsing AW (2010) Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer 103: 115-119
25. Shor R, Wainstein J, Oz D, Boaz M, Matas Z, Fux A, Halabe A (2008) Low HDL levels and the risk of death, sepsis and malignancy. Clin Res Cardiol 97: 227-233 (Pubitemid 351464523)
26. Smith L, Lucas D, Lehnus G (1979) Automated measurement of total cholesterol and triglycerides, in 'tandem,' on the discrete sample analyzer, Gilford System 3500. Clin Chem 25: 439-442 (Pubitemid 9142872)
27. Tabet F, Rye KA (2009) High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 116: 87-98
28. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2004) Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 80: 38-44 (Pubitemid 41115552)
29. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163
30. WHO/IASO/IOTF (2000) The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Health Communications Australia Pty Ltd: Australia, Melbourne, Full document available from http://www. wpro.who.int/NR/rdonlyres/0A35147B- B1D5-45A6-9FF2-F7D86608A4DE/0/Redefiningobesity.pdf